ArriVent BioPharma (AVBP) Earnings Date & Reports

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

AVBP is expected to report earnings to -103 cents per share on November 18

ArriVent BioPharma AVBP Stock Earnings Reports

Q3'26

Est.

$-1.04

Q2'26

Missed

by $0.13

Q1'26

Missed

by $0.12

Q4'25

Missed

by $0.02

Q3'25

Missed

by $0.04

The last earnings report on August 12 showed earnings per share of -104 cents, missing the estimate of -92 cents. With 111.19K shares outstanding, the current market capitalization sits at 1.44B.

View a ticker or compare two or three

AVBP

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for AVBP